July 23, 2021

Arcellx: Plug and Play CAR-T: Modular Immunotherapy

Arcellx: Plug and Play CAR-T: Modular Immunotherapy

From a training at the bedside to a benchtop at the NIH, to the realities of life on the Dark Side, Arcellex CMO, Dr. Chris Heery speaks of his passion of all things immunologic, and in particular, the Arcellx platform that can target, activate, and control a CAR-T cell with their proprietary SparX plug. He also recalls the time he had to face a room full of angry biotech investors (N=50 or more): a textbook example of grace under fire.